TrialEuropean journal of heart failure2021

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial.

Mark R Hazebroek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.